Position in IMRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,999,955
+$3,584,855 QoQ
Shares Held
1,001,995
+273.2% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 111 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. IMRX ranks #214 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in IMRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,999,955 | 1,001,995 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,415,100 | 268,520 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,806,726 | 2,402,238 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,210,048 | 172,864 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $328,018 | 97,335 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $119,373 | 78,535 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $172,777 | 78,535 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $172,395 | 69,235 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $88,620 | 69,235 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,089,229 | 376,896 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,746,415 | 373,662 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,774,753 | 361,296 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,382,927 | 333,622 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $521,766 | 53,735 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $262,069 | 54,035 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $417,213 | 29,135 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $135,439 | 25,035 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,141,825 | 176,480 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,939,445 | 119,941 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,686,913 | 101,202 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||